Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 May;27(5):720–723. doi: 10.1128/aac.27.5.720

Effect of pentobarbital anesthesia on amikacin concentrations in plasma and perilymph and evaluation of multiple sampling in perilymph of guinea pigs.

S Desjardins-Giasson, A R Beaubien, M J Cauchy
PMCID: PMC180140  PMID: 4015068

Abstract

The purpose of this study was to determine whether a multiple-sampling procedure could be used in guinea pigs to study the kinetics of amikacin in perilymph. Amikacin was infused intravenously for 6 h into conscious anesthetized guinea pigs, and the concentrations of the drug in plasma and perilymph were measured. From each anesthetized guinea pig, five to six perilymph samples were collected from one ear, and one sample was collected from the other ear at 6 h. The concentrations of amikacin in perilymph were dose proportional and increased slowly during the 6-h infusion. However, after 6 h of intravenous infusion, the concentrations of amikacin in perilymph of the multiply sampled ears were significantly higher than those of the singly sampled ears, indicating that the multiple-sampling procedure should not be used as is to study the kinetics of amikacin in perilymph. Amikacin concentrations in perilymph were linearly related to amikacin concentrations in plasma in pentobarbital-anesthetized animals, as had previously been observed for conscious guinea pigs. However, the slope of the regression line was only 0.09 for anesthetized animals compared with 0.24 for conscious animals. Drug concentrations in plasma were found to be threefold higher in anesthetized animals, whereas drug levels in perilymph were the same in both groups at similar dosing rates. These results indicate that the amikacin concentration in perilymph is not solely dependent upon its concentration in plasma and that other factor(s) can affect the entry of amikacin into the inner ear.

Full text

PDF
720

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brummett R. E., Fox K. E., Bendrick T. W., Himes D. L. Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig. J Antimicrob Chemother. 1978 May;4 (Suppl A):73–83. doi: 10.1093/jac/4.suppl_a.73. [DOI] [PubMed] [Google Scholar]
  2. Cabana B. E., Taggart J. G. Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans. Antimicrob Agents Chemother. 1973 Apr;3(4):478–483. doi: 10.1128/aac.3.4.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chung M., Parravicini L., Assael B. M., Cavanna G., Radwanski E., Symchowicz S. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs. Antimicrob Agents Chemother. 1982 Dec;22(6):1017–1021. doi: 10.1128/aac.22.6.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Desjardins-Giasson S., Beaubien A. R. Correlation of amikacin concentrations in perilymph and plasma of continuously infused guinea pigs. Antimicrob Agents Chemother. 1984 Jul;26(1):87–90. doi: 10.1128/aac.26.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Federspil P., Schätzle W., Tiesler E. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin. J Infect Dis. 1976 Aug;134 (Suppl):S200–S205. doi: 10.1093/infdis/134.supplement_1.s200. [DOI] [PubMed] [Google Scholar]
  6. Higashi Y., Notoji N., Yamajo R., Yata N. Effect of anesthesia on drug disposition in the rat. J Pharmacobiodyn. 1982 Feb;5(2):112–119. doi: 10.1248/bpb1978.5.112. [DOI] [PubMed] [Google Scholar]
  7. Mirhij N. J., Roberts R. J., Myers M. G. Effects of hypoxemia upon aminoglycoside serum pharmacokinetics in animals. Antimicrob Agents Chemother. 1978 Sep;14(3):344–347. doi: 10.1128/aac.14.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Myers M. G., Roberts R. J., Mirhij N. J. Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants. Antimicrob Agents Chemother. 1977 Jun;11(6):1027–1032. doi: 10.1128/aac.11.6.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ohtani I., Ohtsuki K., Aikawa T., Omata T., Ouchi J., Saito T. Individual variation and mechanism of kanamycin ototoxicity in rabbits. Acta Otolaryngol. 1982 Nov-Dec;94(5-6):413–419. doi: 10.3109/00016488209128929. [DOI] [PubMed] [Google Scholar]
  10. Pittinger C., Adamson R. Antibiotic blockade of neuromuscular function. Annu Rev Pharmacol. 1972;12:169–184. doi: 10.1146/annurev.pa.12.040172.001125. [DOI] [PubMed] [Google Scholar]
  11. Stupp H., Küpper K., Lagler F., Sous H., Quante M. Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application. Audiology. 1973 Sep-Dec;12(5):350–363. doi: 10.3109/00206097309071650. [DOI] [PubMed] [Google Scholar]
  12. Tran Ba Huy P., Manuel C., Meulemans A., Sterkers O., Amiel C. Pharmacokinetics of gentamicin in perilymph and endolymph of the rat as determined by radioimmunoassay. J Infect Dis. 1981 Mar;143(3):476–486. doi: 10.1093/infdis/143.3.476. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES